v3.26.1
Segment Reporting - Schedule Segment Profit or Loss, Including Significant Segment Expenses (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Segment Reporting Information [Line Items]    
Total general and administrative expenses $ 12,742 $ 7,455
Total operating expenses 60,242 41,788
Operating loss (60,242) (41,788)
Interest income 4,083 5,014
Total other income 4,083 5,014
Net income before losses (56,159) (36,774)
Net loss (56,211) (36,846)
Reportable Segment    
Segment Reporting Information [Line Items]    
Manufacturing and process development 14,570 10,026
Clinical operations and development 23,208 18,655
Research and development personnel cost and other (including stock-based compensation) 9,121 5,096
Research 601 556
Total research and development 47,500 34,333
General and administrative personnel costs (including stock-based compensation) 7,963 4,832
Professional fees 3,560 1,504
Facility costs, IT, office expense and other 1,219 1,119
Total general and administrative expenses 12,742 7,455
Total operating expenses 60,242 41,788
Operating loss (60,242) (41,788)
Interest income 4,083 5,014
Total other income 4,083 5,014
Net income before losses (56,159) (36,774)
Income tax expense (52) (72)
Net loss $ (56,211) $ (36,846)